Project Grant R01AR084561
Award Date
6/15/25
Completion Date
4/30/30
Dollars Obligated
$624K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Burlington, VT 05405, USA
Similar Awards
The federal Project Grant award of $589,255, issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to develop small RNA targeting approaches for treating heterotopic ossification (HO). The project aims to: (I) test new nanoparticle-based strategies to treat HO, which involves pathological bone formation in soft tissues, and (II) advance the...
This federal Project Grant award, ID R01AR084693, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The $1,938,605 award to the Van Andel Research Institute (VAI) in Grand Rapids, Michigan will fund research to determine the mechanisms by which the X-linked chromatin modifying enzyme KDM5C regulates bone mass in females. The project aims to investigate how loss...
This $313,000 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund research by Emory University to establish phosphorylated WNT5A produced by osteoclasts as a potential anabolic bone drug. The research aims to determine how osteoclast-derived phospho-WNT5A can enhance bone formation in vivo and elucidate the cellular and molecular mechanisms by...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $599,693 to support research into the negative regulation of osteoclastogenesis - the process of generating bone-resorbing cells. The overarching goals are to elucidate the molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis under...
This federal Project Grant award of $595,117 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to develop carrier-free siRNA conjugates as disease-modifying osteoarthritis drugs. The project aims to elucidate the mechanism of action of siRNA-L2 against MMP13 in osteoarthritis, test new chemical modifications to improve joint retention and activity of...
This federal Project Grant award of $647,460 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research to identify the mechanisms responsible for the ultra-rapid induction of mechanoresponsive genes in skeletal muscle cells. The research, to be conducted by Cornell University over a 5-year period from 2024 to 2029, aims to determine how the nucleus actively...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $626,879 to the University of Southern California to conduct research on cellular and molecular mechanisms driving large-scale bone regeneration. The research aims to unravel the intricate cellular and molecular events necessary for extensive bone repair, focusing on understanding...
This federal Project Grant award in the amount of $375,100.00, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the cellular mechanisms of age-associated cortical bone remodeling. The two-year deliverables of the proposed study are: 1) identification of myeloid progenitors that aid in maintenance of cortical bone with age, and 2)...
This federal Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is focused on building a comprehensive data repository to collect and share bone phenotyping data from rodent animal models. The total award amount is $522,334.00, with a project period from September 2024 through July 2028. The key products and services to be delivered include:...
This federal Project Grant award of $249,000.00 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to resolve the mechanism of osteoclast multinucleation and signaling in bone remodeling. The key products and services to be delivered include: Identifying the lupus LA protein domain that regulates osteoclast multinucleation through a semi-automated peptide...